Dr. Westin will focus on known molecular abnormalities that have allowed the field of precision medicine blossom in ovarian cancer.

Novel targeted therapies including PARP inhibitors and anti-angiogenics will be featured.

We thank Merck for their generous support of this program.

Seminar Information
Date Presented:
December 12, 2017 1:00 PM Eastern
Length:
1 hour, 30 minutes
Registration Fee:
Free
Registration for this event is closed
Precision Medicine in Ovarian Cancer
Speaker Information
Shannon Westin MD  [ view bio ]
Individual topic purchase: Selected